
Cell Therapy, Plan to Deliver Process Intern
AstraZeneca
Summary
We are looking for undergraduate students majoring in Management & Business Operations, Human Resources, or a related field for a 10-week internship role at our site in Tarzana, CA from June 7, 2027 to August 13, 2027.
Job description
Position Description
- Catalog existing procedures, work instructions, process maps, etc. to support training resources related to Plan to Deliver activities.
- Develop a structured catalogue that captures documents and training relevance for training assignment by function and job responsibilities.
- Map core processes and identify documentation gaps both at a site and global level.
Position Requirements
- Undergraduate students majoring in Management & Business Operations, Human Resources, or a related field.
- Experience with supply chain, project management, and process streamlining is required.
- Candidates must have an expected graduation date after August 2027.
- US Work Authorization is required at time of application.
- This role will not be granting CPT support.
- Ability to report onsite to Tarzana, CA site 3 days per week. This role will not provide relocation assistance.
- Compensation: $27 per hour.
Requirements
- Undergraduate student majoring in Management & Business Operations, Human Resources, or a related field
- Experience with supply chain, project management, and process streamlining
- Expected graduation date after August 2027
- US Work Authorization required at time of application
- No CPT support provided
- Ability to report onsite to Tarzana, CA site 3 days per week
- No relocation assistance provided
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.